<DOC>
	<DOCNO>NCT02168179</DOCNO>
	<brief_summary>This pilot clinical trial study KeraStat Skin Therapy treat radiation dermatitis patient newly diagnose stage 0-IIIA breast cancer . Radiation dermatitis itchy , painful skin rash occur follow treatment radiation . KeraStat Skin Therapy may better treatment radiation dermatitis .</brief_summary>
	<brief_title>KeraStat Skin Therapy Treating Radiation Dermatitis Patients With Newly Diagnosed Stage 0-IIIA Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To obtain preliminary estimate incidence early adverse skin reaction ( EASR ) radiation therapy ( RT ) two month post RT application cosmetic cream KeraStat Skin Therapy RT breast cancer patient pilot study . SECONDARY OBJECTIVES : I . To associate personal characteristic ( e.g. , race/ethnicity , age , hormone therapy , smoke status , comorbidities , breast size ) treatment characteristic ( e.g. , RT dose ) incidence EASR time point . OUTLINE : Patients apply KeraStat Skin Therapy topically twice daily ( BID ) radiation therapy . After completion study treatment , patient follow 1 2 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Ductal , Breast</mesh_term>
	<mesh_term>Carcinoma , Intraductal , Noninfiltrating</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<criteria>Newly diagnose breast carcinoma , stage 0IIIA ( include ductal carcinoma situ [ DCIS ] ) Status postlumpectomy , quadrantectomy , mastectomy Plan receive adjuvant radiation whole breast chest wall +/ regional lymph node Total dose &gt; = 40Gy Dose per fraction &gt; = 1.8 use 2dimensional ( 2D ) , 3dimensional ( 3D ) conformal , intensitymodulated radiation therapy ( IMRT ) treatment technique allow ; skin spar IMRT patient exclude ; daily fraction 2.7 Gy whole breast suggest hypofractionated regimen Concurrent sequential boost technique allow standard hypofractionated regimen Adjuvant hormonal therapy allow prior , and/or RT discretion medical oncologist Targeted therapy Herceptin allow prior , , and/or RT discretion medical oncologist Patients able willing sign protocol consent form Prior radiation involve breast chest wall Concurrent chemotherapy ; ( patient may receive chemotherapy prior radiation follow radiation treat physician 's discretion ) Patients underwent breast reconstruction follow mastectomy ( placement tissue expanders implant allow ) Patients undergo partial breast irradiation Patients undergone MammoSiteÂ® form brachytherapy Patients may concurrently enrol protocol involve treatment skin ie : applying lotion /moisturizers ; protocol involve treatment skin allow Patients pregnant breastfeeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>